These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34693621)

  • 21. Food for thought-The link between Clostridioides difficile metabolism and pathogenesis.
    Marshall A; McGrath JW; Graham R; McMullan G
    PLoS Pathog; 2023 Jan; 19(1):e1011034. PubMed ID: 36602960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-omics investigation of
    Fishbein SR; Robinson JI; Hink T; Reske KA; Newcomer EP; Burnham CD; Henderson JP; Dubberke ER; Dantas G
    Elife; 2022 Jan; 11():. PubMed ID: 35083969
    [No Abstract]   [Full Text] [Related]  

  • 23. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
    Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
    BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbe-microbe interactions during Clostridioides difficile infection.
    Abbas A; Zackular JP
    Curr Opin Microbiol; 2020 Feb; 53():19-25. PubMed ID: 32088581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of environmental conditions and gut microbiota on the in vitro germination and growth of Clostridioides difficile.
    Martinez E; Rodriguez C; Crèvecoeur S; Lebrun S; Delcenserie V; Taminiau B; Daube G
    FEMS Microbiol Lett; 2022 Oct; 369(1):. PubMed ID: 36066913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a 1,2,4-Oxadiazole with Potent and Specific Activity against
    Barbachyn MR
    J Med Chem; 2023 Oct; 66(20):13888-13890. PubMed ID: 37823241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A short chain fatty acid-centric view of Clostridioides difficile pathogenesis.
    Gregory AL; Pensinger DA; Hryckowian AJ
    PLoS Pathog; 2021 Oct; 17(10):e1009959. PubMed ID: 34673840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The high prevalence of
    Haran JP; Ward DV; Bhattarai SK; Loew E; Dutta P; Higgins A; McCormick BA; Bucci V
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33764826
    [No Abstract]   [Full Text] [Related]  

  • 29. Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans.
    Gu W; Li W; Wang W; Kuang D; Zhang W; Lu C; Li N; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
    BMC Microbiol; 2020 Aug; 20(1):260. PubMed ID: 32819295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disordered Intestinal Microbial Communities During
    Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
    Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-colonization with the fungus
    Romo JA; Tomihiro M; Kumamoto CA
    mSphere; 2023 Aug; 8(4):e0012223. PubMed ID: 37358292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction.
    Auchtung JM; Preisner EC; Collins J; Lerma AI; Britton RA
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32727857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
    Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
    Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbiota Diversity of Preterm Neonates Is Associated With
    Couturier J; Lepage P; Jolivet S; Delannoy J; Mesa V; Ancel PY; Rozé JC; Butel MJ; Barbut F; Aires J
    Front Cell Infect Microbiol; 2022; 12():907323. PubMed ID: 35873148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiome therapeutics for the treatment of recurrent
    Bloom PP; Young VB
    Expert Opin Biol Ther; 2023 Jan; 23(1):89-101. PubMed ID: 36536532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Clostridioides difficile-Inhibiting Gut Commensals Using Culturomics, Phenotyping, and Combinatorial Community Assembly.
    Ghimire S; Roy C; Wongkuna S; Antony L; Maji A; Keena MC; Foley A; Scaria J
    mSystems; 2020 Feb; 5(1):. PubMed ID: 32019832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Stickland Reaction Precursor
    Reed AD; Fletcher JR; Huang YY; Thanissery R; Rivera AJ; Parsons RJ; Stewart AK; Kountz DJ; Shen A; Balskus EP; Theriot CM
    mSphere; 2022 Apr; 7(2):e0092621. PubMed ID: 35350846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.